Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Shelley Chu purchased 11,111 shares of the company’s stock in a transaction on Monday, May 11th. The stock was acquired at an average cost of $18.00 per share, for a total transaction of $199,998.00. Following the completion of the purchase, the director owned 11,111 shares of the company’s stock, valued at approximately $199,998. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Odyssey Therapeutics Stock Up 6.3%
Shares of ODTX stock traded up $1.03 during trading hours on Monday, hitting $17.45. 426,992 shares of the company were exchanged. Odyssey Therapeutics, Inc. has a fifty-two week low of $15.35 and a fifty-two week high of $20.30.
Further Reading
- Five stocks we like better than Odyssey Therapeutics
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
